Fallopian Tube Cancer
📧 Sign up to get email alerts when something new happens for Fallopian Tube Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-11-24Clinical Trial Update: A Survivorship Care Plan for Gynaecological Cancer Patients
This completed clinical trial update reports on a survivorship care plan study for gynecologic cancer patients sponsored by Royal Marsden NH…
-
CLINICAL_TRIALS trial_result · 2017-11-21Clinical Trial Update: A Phase I Study of ABT-888 in Combination With Temozolomide in Cancer Patients [Phase 1]
Phase I study evaluating ABT-888 (veliparib) with temozolomide in patients with various cancers, including metastatic melanoma. The trial st…
-
CLINICAL_TRIALS trial_result · 2017-11-21Clinical Trial Update: Veliparib and Radiation Therapy in Treating Patients With Advanced Solid Malignancies With Peritoneal Carcinomatosis, Epithelial Ovarian, Fallopian, or Primary Peritoneal Cancer [Phase 1]
Phase 1 trial evaluating veliparib in combination with radiation therapy in adults with advanced solid tumors featuring peritoneal carcinoma…
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: Intraoperative Detection of Lesions Using PET (Positron Emission Tomography) Probe During Secondary Cytoreductive Surgery for Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancer [NA]
This study assessed intraoperative detection of cancer lesions using a PET probe during secondary cytoreductive surgery for recurrent ovaria…
-
CLINICAL_TRIALS trial_result · 2017-09-07Clinical Trial Update: Rilotumumab in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial of rilotumumab in persistent/recurrent ovarian, fallopian tube, or primary peritoneal cancer has completed; results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-09-06Clinical Trial Update: OPT-821 With or Without Vaccine Therapy in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in Second or Third Complete Remission [Phase 2]
Phase 2 clinical trial evaluating OPT-821 with or without vaccine therapy in ovarian, fallopian tube, or primary peritoneal cancer in second…
-
CLINICAL_TRIALS trial_result · 2017-08-28Clinical Trial Update: Sargramostim and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Previous Chemotherapy [Phase 2]
This Phase 2 trial evaluated the combination of sargramostim with paclitaxel albumin-stabilized nanoparticle formulation in patients with ad…
-
CLINICAL_TRIALS trial_result · 2017-08-10Clinical Trial Update: Intraperitoneal vs Intravenous Chemotherapy Following Neoadjuvant Chemotherapy in Ovarian Cancer [Phase 2]
Phase 2 clinical trial comparing intraperitoneal versus intravenous chemotherapy after neoadjuvant treatment in ovarian cancer has completed…
-
CLINICAL_TRIALS trial_result · 2017-07-19Clinical Trial Update: Feasibility of Interval Debulking Surgery by Laparoscopy for Peritoneal Carcinosis in Chemosensitive Patients [Phase 2]
A Phase 2 trial evaluated the feasibility of performing interval debulking surgery via laparoscopy for chemosensitive peritoneal carcinomato…
-
CLINICAL_TRIALS trial_result · 2017-07-18Clinical Trial Update: Detection of Chlamydia DNA by Polymerase Chain Reaction in Primary Tubal and Ovarian Cancers Tissues : a Pilot Study
A pilot clinical trial update evaluating whether Chlamydia DNA can be detected by PCR in tissues from primary fallopian tube cancers and ova…
-
CLINICAL_TRIALS trial_result · 2017-07-12Clinical Trial Update: Bevacizumab With or Without Fosbretabulin Tromethamine in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer [Phase 2]
Phase 2 trial evaluating bevacizumab with or without fosbretabulin tromethamine in recurrent or persistent ovarian epithelial, fallopian tub…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Cediranib Maleate in Treating Patients With Persistent, Recurrent, or Refractory Advanced Ovarian Epithelial, Peritoneal Cavity, or Fallopian Tube Cancer [Phase 2]
Phase 2 clinical trial evaluating cediranib maleate in patients with persistent, recurrent, or refractorily advanced ovarian epithelial, fal…
-
CLINICAL_TRIALS trial_result · 2017-06-09Clinical Trial Update: Second-line Intravenous Treatment For Recurrent Platinum-Sensitive Ovarian, Fallopian, Or Peritoneal Cancer [Phase 2]
A Phase 2 trial conducted by GlaxoSmithKline evaluating a second-line intravenous therapy for recurrent platinum-sensitive ovarian, fallopia…
-
CLINICAL_TRIALS trial_result · 2017-05-31Clinical Trial Update: Efficacy Study of FloSeal for Prevention of Lymphocele After Lymphadenectomy for Gynecologic Cancer [NA]
Completed efficacy trial evaluating FloSeal for prevention of lymphocele after lymphadenectomy in gynecologic cancer.
-
CLINICAL_TRIALS trial_result · 2017-05-24Clinical Trial Update: RO4929097 in Treating Patients With Recurrent and/or Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial of RO4929097 in recurrent/metastatic epithelial ovarian cancer, fallopian tube cancer, and primary peritoneal cancer has compl…
-
CLINICAL_TRIALS trial_result · 2017-05-18Clinical Trial Update: Feasibility Trial of Intraperitoneal Chemotherapy for Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma [Phase 2]
A Phase 2 feasibility trial evaluating intraperitoneal chemotherapy for ovarian, fallopian tube, and primary peritoneal carcinomas has been …
-
CLINICAL_TRIALS trial_result · 2017-05-08Clinical Trial Update: GM-CSF, Sargramostim in Women With Recurrent Ovarian Cancer [Phase 2]
Phase 2 clinical trial results for GM-CSF (sargramostim) in women with recurrent ovarian cancer (including fallopian tube cancer) have been …
-
CLINICAL_TRIALS trial_result · 2017-04-21Clinical Trial Update: Phase 1 Study of a Cancer Vaccine to Treat Patients With Advanced Stage Ovarian, Fallopian or Peritoneal Cancer [Phase 1]
A Phase 1 trial of an ImmunoVaccine Technologies cancer vaccine for advanced ovarian cancer, fallopian tube cancer, or peritoneal cancer has…
-
CLINICAL_TRIALS trial_result · 2017-03-20Clinical Trial Update: Guided Imagery in the Perioperative Period in Gynecologic Oncology Patients [NA]
The University of Michigan completed a clinical trial evaluating guided imagery as a perioperative intervention in gynecologic oncology pati…
-
CLINICAL_TRIALS trial_result · 2017-03-14Clinical Trial Update: Unimolecular Pentavalent (Globo-H-GM2-sTn-TF-Tn) Immunization of Patients With Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer in First Remission [Phase 1]
A Phase 1 study of a unimolecular pentavalent immunization (Globo-H-GM2-sTn-TF-Tn) in patients with epithelial ovarian cancer, fallopian tub…
-
CLINICAL_TRIALS trial_result · 2017-02-24Clinical Trial Update: Allogeneic Natural Killer (NK) Cells for Ovarian, Fallopian Tube, Peritoneal and Metastatic Breast Cancer [Phase 2]
Phase 2 trial update on allogeneic natural killer (NK) cells for ovarian, fallopian tube, peritoneal, and metastatic breast cancer; study co…
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer [Phase 3]
This is a Phase 3 clinical trial evaluating whether intravenous glutathione can prevent paclitaxel/carboplatin-induced peripheral neuropathy…
-
CLINICAL_TRIALS trial_result · 2017-02-13Clinical Trial Update: Effects of STM 434 Alone or in Combination With Liposomal Doxorubicin in Patients With Ovarian Cancer or Other Advanced Solid Tumors [Phase 1]
Phase 1 trial evaluating STM-434 alone or with liposomal doxorubicin in ovarian cancer, fallopian tube cancer, endometrial cancer, and other…
-
CLINICAL_TRIALS trial_result · 2017-01-18Clinical Trial Update: Lenalidomide and Doxorubicin Hydrochloride Liposome in Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial of lenalidomide with doxorubicin liposome in recurrent ovarian, fallopian tube, or primary peritoneal cancer; the s…
-
CLINICAL_TRIALS trial_result · 2017-01-12Clinical Trial Update: Therapeutic Targeting of Stress Factors in Ovarian Cancer Patients [Phase 1]
A Phase 1 clinical trial update evaluating therapeutic targeting of stress factors in ovarian cancer; status is completed.